Key result
Treat-to-target strategies using objective measures guide aggressive therapy to reach optimal rheumatoid arthritis endpoints.
Why the study?
Appropriate treatment targets in rheumatoid arthritis remain elusive despite the importance of preventing joint damage, minimizing disability, and improving mortality.
Do treat-to-target strategies using objective disease measures improve outcomes in patients with rheumatoid arthritis?
Do treat-to-target strategies using objective disease measures improve outcomes in patients with rheumatoid arthritis?
This review highlights the critical importance of using objective composite measures of disease activity to guide treat-to-target strategies in rheumatoid arthritis.
No takes yet. Share an insight, caveat, or question.
Should not yet change RA practice; leaves open need for randomized confirmation of objective treat-to-target benefits.
Hobbs et al. (2012) conducted a review in Rheumatoid arthritis. Treat-to-target strategies using objective disease measures was evaluated. Objective measures of disease activity can guide aggressive treatment to reach defined optimal endpoints in rheumatoid arthritis, supporting treat-to-target strategies.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: